C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism
- PMID: 32460534
- PMCID: PMC7717311
- DOI: 10.1177/2047487320931305
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism
Comment in
-
C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19.Eur J Prev Cardiol. 2020 Aug;27(12):1333-1334. doi: 10.1177/2047487320931999. Epub 2020 Jun 9. Eur J Prev Cardiol. 2020. PMID: 32517505 Free PMC article. No abstract available.
Comment on
-
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases.Eur J Prev Cardiol. 2020 Sep;27(13):1436-1437. doi: 10.1177/2047487320922370. Epub 2020 Apr 28. Eur J Prev Cardiol. 2020. PMID: 32343152 Free PMC article. Review. No abstract available.
References
-
- Cavalli-Sforza LL, Menozzi P, Piazza A The history and geography of human genes. Princeton, NJ: Princeton University Press, 1994.
-
- Delanghe JR, Speeckaert MM, de Buyzere ML COVID-19 infections are also affected by human ACE1 D/I polymorphism. Clin Chem Lab Med Epub ahead of print 14 April 2020. DOI: 10.1515/cclm-2020-0425. - PubMed
-
- Delanghe JR, Speeckaert R, Speeckaert MM Complement C3 and its polymorphism: biological and clinical consequences. Pathology 2014; 46: 1–10. - PubMed
-
- Henry S, Oriol R, Samuelsson B Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995; 69: 166–182. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous